INSP Stock Recent News
INSP LATEST HEADLINES
Inspire Medical Systems NYSE: INSP is up nearly 15% since breaking out of cup-with-handle base on May 3. The base's buy point was above $277.18, which you can see on the Inspire Medical Systems chart.
MINNEAPOLIS, July 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2023 after the close of trading on Tuesday, August 1. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Investors are optimistic about Inspire Medical's (INSP) global presence.
Inspire Medical has multiple catalysts in the pipeline that could see it attract investment. These center around fundamental, sentimental and valuation factors. The company could be fairly valued at $317/share, indicating potential mispricing.
The FDA approves Inspire's (INSP) application to expand the indication to include patients with AHI up to 100 events per hour.
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023
MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Travis Steed - Bank of America John Block - Stifel Adam Maeder - Piper Sandler Rich Newitter - Truist Chris Pasquale - Nephron Research Matthew Mishan - KeyBanc Anthony Petrone - Mizuho Security Suraj Kalia - Oppenheimer Michael Polark - Wolfe Research Operator Good afternoon. My name is Del [ph] and I'll be your conference operator today.
Inspire Medical Systems (INSP) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.61 per share a year ago.
MINNEAPOLIS, April 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.